PittCoVacc

N/A

Report date: 2025/01/26 15:50:29

Base Information

Drug NamePittCoVacc
Drug Alias NameMNA SARS-CoV-2 subunit vaccine (University of Pittsburgh School of Medicine)Pittsburgh Coronavirus Vaccine (University of Pittsburgh School of Medicine)SARS-CoV-2 subunit vaccine (University of Pittsburgh School of Medicine)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh School Of Medicine
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A